Company Information
Industry 制造业
Company Introduction 江苏四环生物股份有限公司是一家以生物医学技术及传统医药相结合的现代化药品生产企业,主营肝炎诊断试剂、注射剂、体外诊断试剂等.主要产品有重组人白细胞介素-2、重组人表皮生长因子、重组人粒细胞集落刺激因子、重组人红细胞生成素、肝炎诊断试剂、体外诊断试剂、注射剂等.公司拥有年产2000万瓶(袋)的输液车间,3亿支的针剂车间,30亿片(粒)的固体制剂车间,500万瓶的中药酒剂车间,年产1000吨的原料车间.公司还拥有从国外引进的非PVC软包输液生产线、傅立叶红外光谱仪、水处理系统、胶囊填充机等先进设备。
Main Business 主要从事生物医药制品、生产和销售以及园林绿化工程业务。
Legal Representative 郭煜
Top Executives
董事长:郭煜
董事:文军,郭煜
独立董事:刘卫,吴良卫,王莉
Top 5 Shareholder
Shareholder name Nature Holding Date
郁琴芬流通A股14.32%30/09/2024
王洪明流通A股14.00%30/09/2024
昆山市创业投资有限公司流通A股6.63%30/09/2024
广州盛景投资有限公司流通A股2.91%30/09/2024
陈建国流通A股2.53%30/09/2024
Company Secretary 郭煜
Solicitors 江苏世纪同仁律师事务所
Auditors 江苏公证会计师事务所有限公司
Tel No 0510-86408558
Fax No 0510-86408558
Website www.000518shsw.com
Email 0518shsw@163.com
Company Address
Register: 江苏省江阴市滨江开发区定山路10号
Office: 江苏省江阴市新桥镇新郁路中房6号
Listing Date 08/09/1993
Shares Capital
Shares Capital: 1,029,556,222
Total A Share: 1,029,556,222
Listed A Share: 1,029,535,693
Non-tradable A Share: 20,529
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.073
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 0.468
Market Capitalization(RMB) 3.480B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.